nodes	percent_of_prediction	percent_of_DWPC	metapath
Olopatadine—Cyclobenzaprine—Tamoxifen—pancreatic cancer	0.583	1	CrCrCtD
Olopatadine—S100A2—islet of Langerhans—pancreatic cancer	0.00372	0.294	CbGeAlD
Olopatadine—S100A2—pancreas—pancreatic cancer	0.00262	0.207	CbGeAlD
Olopatadine—S100A1—digestive system—pancreatic cancer	0.00206	0.162	CbGeAlD
Olopatadine—S100A13—digestive system—pancreatic cancer	0.00182	0.144	CbGeAlD
Olopatadine—S100A12—digestive system—pancreatic cancer	0.0018	0.142	CbGeAlD
Olopatadine—Vision blurred—Fluorouracil—pancreatic cancer	0.000523	0.00239	CcSEcCtD
Olopatadine—Malaise—Irinotecan—pancreatic cancer	0.000523	0.00239	CcSEcCtD
Olopatadine—Infestation—Docetaxel—pancreatic cancer	0.000513	0.00235	CcSEcCtD
Olopatadine—Infestation NOS—Docetaxel—pancreatic cancer	0.000513	0.00235	CcSEcCtD
Olopatadine—Dyspnoea—Sunitinib—pancreatic cancer	0.000512	0.00234	CcSEcCtD
Olopatadine—Malaise—Gemcitabine—pancreatic cancer	0.000509	0.00233	CcSEcCtD
Olopatadine—Cough—Irinotecan—pancreatic cancer	0.000506	0.00231	CcSEcCtD
Olopatadine—Conjunctivitis—Docetaxel—pancreatic cancer	0.000499	0.00228	CcSEcCtD
Olopatadine—Eye pain—Epirubicin—pancreatic cancer	0.000497	0.00227	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Sunitinib—pancreatic cancer	0.000496	0.00227	CcSEcCtD
Olopatadine—Fatigue—Sunitinib—pancreatic cancer	0.000495	0.00226	CcSEcCtD
Olopatadine—Hypersensitivity—Tamoxifen—pancreatic cancer	0.000494	0.00226	CcSEcCtD
Olopatadine—Cough—Gemcitabine—pancreatic cancer	0.000493	0.00225	CcSEcCtD
Olopatadine—Pain—Sunitinib—pancreatic cancer	0.000491	0.00225	CcSEcCtD
Olopatadine—Discomfort—Irinotecan—pancreatic cancer	0.000488	0.00223	CcSEcCtD
Olopatadine—Epistaxis—Docetaxel—pancreatic cancer	0.000484	0.00221	CcSEcCtD
Olopatadine—Asthenia—Tamoxifen—pancreatic cancer	0.000481	0.0022	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—pancreatic cancer	0.000478	0.00218	CcSEcCtD
Olopatadine—Asthenia—Erlotinib—pancreatic cancer	0.000476	0.00218	CcSEcCtD
Olopatadine—Discomfort—Gemcitabine—pancreatic cancer	0.000475	0.00217	CcSEcCtD
Olopatadine—Pruritus—Tamoxifen—pancreatic cancer	0.000475	0.00217	CcSEcCtD
Olopatadine—Oedema—Irinotecan—pancreatic cancer	0.000473	0.00216	CcSEcCtD
Olopatadine—Infection—Irinotecan—pancreatic cancer	0.00047	0.00215	CcSEcCtD
Olopatadine—Gastrointestinal pain—Sunitinib—pancreatic cancer	0.00047	0.00215	CcSEcCtD
Olopatadine—Pruritus—Erlotinib—pancreatic cancer	0.00047	0.00215	CcSEcCtD
Olopatadine—Discomfort—Fluorouracil—pancreatic cancer	0.000467	0.00214	CcSEcCtD
Olopatadine—Nervous system disorder—Irinotecan—pancreatic cancer	0.000464	0.00212	CcSEcCtD
Olopatadine—Rhinitis—Docetaxel—pancreatic cancer	0.000462	0.00211	CcSEcCtD
Olopatadine—Oedema—Gemcitabine—pancreatic cancer	0.000461	0.00211	CcSEcCtD
Olopatadine—Eye pain—Doxorubicin—pancreatic cancer	0.00046	0.0021	CcSEcCtD
Olopatadine—Diarrhoea—Tamoxifen—pancreatic cancer	0.000459	0.0021	CcSEcCtD
Olopatadine—Hypoaesthesia—Docetaxel—pancreatic cancer	0.000458	0.00209	CcSEcCtD
Olopatadine—Infection—Gemcitabine—pancreatic cancer	0.000458	0.00209	CcSEcCtD
Olopatadine—Pharyngitis—Docetaxel—pancreatic cancer	0.000457	0.00209	CcSEcCtD
Olopatadine—Abdominal pain—Sunitinib—pancreatic cancer	0.000454	0.00208	CcSEcCtD
Olopatadine—Body temperature increased—Sunitinib—pancreatic cancer	0.000454	0.00208	CcSEcCtD
Olopatadine—Diarrhoea—Erlotinib—pancreatic cancer	0.000454	0.00208	CcSEcCtD
Olopatadine—Oedema—Fluorouracil—pancreatic cancer	0.000453	0.00207	CcSEcCtD
Olopatadine—Nervous system disorder—Gemcitabine—pancreatic cancer	0.000452	0.00207	CcSEcCtD
Olopatadine—Infection—Fluorouracil—pancreatic cancer	0.00045	0.00206	CcSEcCtD
Olopatadine—Skin disorder—Gemcitabine—pancreatic cancer	0.000448	0.00205	CcSEcCtD
Olopatadine—Nervous system disorder—Fluorouracil—pancreatic cancer	0.000445	0.00203	CcSEcCtD
Olopatadine—Visual impairment—Docetaxel—pancreatic cancer	0.000444	0.00203	CcSEcCtD
Olopatadine—Dizziness—Tamoxifen—pancreatic cancer	0.000444	0.00203	CcSEcCtD
Olopatadine—Dizziness—Erlotinib—pancreatic cancer	0.000439	0.00201	CcSEcCtD
Olopatadine—Eye disorder—Docetaxel—pancreatic cancer	0.00043	0.00197	CcSEcCtD
Olopatadine—Vomiting—Tamoxifen—pancreatic cancer	0.000427	0.00195	CcSEcCtD
Olopatadine—Hypersensitivity—Sunitinib—pancreatic cancer	0.000423	0.00194	CcSEcCtD
Olopatadine—Rash—Tamoxifen—pancreatic cancer	0.000423	0.00193	CcSEcCtD
Olopatadine—Dermatitis—Tamoxifen—pancreatic cancer	0.000423	0.00193	CcSEcCtD
Olopatadine—Vomiting—Erlotinib—pancreatic cancer	0.000422	0.00193	CcSEcCtD
Olopatadine—Dyspnoea—Irinotecan—pancreatic cancer	0.000422	0.00193	CcSEcCtD
Olopatadine—Somnolence—Irinotecan—pancreatic cancer	0.000421	0.00192	CcSEcCtD
Olopatadine—Headache—Tamoxifen—pancreatic cancer	0.00042	0.00192	CcSEcCtD
Olopatadine—Rash—Erlotinib—pancreatic cancer	0.000418	0.00191	CcSEcCtD
Olopatadine—Dermatitis—Erlotinib—pancreatic cancer	0.000418	0.00191	CcSEcCtD
Olopatadine—Immune system disorder—Docetaxel—pancreatic cancer	0.000416	0.0019	CcSEcCtD
Olopatadine—Headache—Erlotinib—pancreatic cancer	0.000416	0.0019	CcSEcCtD
Olopatadine—Mediastinal disorder—Docetaxel—pancreatic cancer	0.000415	0.0019	CcSEcCtD
Olopatadine—Asthenia—Sunitinib—pancreatic cancer	0.000412	0.00188	CcSEcCtD
Olopatadine—Dry skin—Epirubicin—pancreatic cancer	0.000412	0.00188	CcSEcCtD
Olopatadine—Dyspnoea—Gemcitabine—pancreatic cancer	0.000411	0.00188	CcSEcCtD
Olopatadine—Somnolence—Gemcitabine—pancreatic cancer	0.00041	0.00187	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	0.000409	0.00187	CcSEcCtD
Olopatadine—Fatigue—Irinotecan—pancreatic cancer	0.000408	0.00187	CcSEcCtD
Olopatadine—Pruritus—Sunitinib—pancreatic cancer	0.000406	0.00186	CcSEcCtD
Olopatadine—Pain—Irinotecan—pancreatic cancer	0.000405	0.00185	CcSEcCtD
Olopatadine—Dyspnoea—Fluorouracil—pancreatic cancer	0.000404	0.00185	CcSEcCtD
Olopatadine—Somnolence—Fluorouracil—pancreatic cancer	0.000403	0.00184	CcSEcCtD
Olopatadine—Nasopharyngitis—Epirubicin—pancreatic cancer	0.000401	0.00184	CcSEcCtD
Olopatadine—Erythema—Docetaxel—pancreatic cancer	0.000401	0.00183	CcSEcCtD
Olopatadine—Nausea—Tamoxifen—pancreatic cancer	0.000398	0.00182	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	0.000398	0.00182	CcSEcCtD
Olopatadine—Fatigue—Gemcitabine—pancreatic cancer	0.000397	0.00182	CcSEcCtD
Olopatadine—Pain—Gemcitabine—pancreatic cancer	0.000394	0.0018	CcSEcCtD
Olopatadine—Nausea—Erlotinib—pancreatic cancer	0.000394	0.0018	CcSEcCtD
Olopatadine—Diarrhoea—Sunitinib—pancreatic cancer	0.000393	0.0018	CcSEcCtD
Olopatadine—Dysgeusia—Docetaxel—pancreatic cancer	0.000393	0.00179	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	0.000391	0.00179	CcSEcCtD
Olopatadine—Feeling abnormal—Irinotecan—pancreatic cancer	0.00039	0.00178	CcSEcCtD
Olopatadine—Influenza—Epirubicin—pancreatic cancer	0.000388	0.00177	CcSEcCtD
Olopatadine—Back pain—Docetaxel—pancreatic cancer	0.000388	0.00177	CcSEcCtD
Olopatadine—Pain—Fluorouracil—pancreatic cancer	0.000388	0.00177	CcSEcCtD
Olopatadine—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000387	0.00177	CcSEcCtD
Olopatadine—Muscle spasms—Docetaxel—pancreatic cancer	0.000385	0.00176	CcSEcCtD
Olopatadine—Dry skin—Doxorubicin—pancreatic cancer	0.000381	0.00174	CcSEcCtD
Olopatadine—Dizziness—Sunitinib—pancreatic cancer	0.00038	0.00174	CcSEcCtD
Olopatadine—Feeling abnormal—Gemcitabine—pancreatic cancer	0.00038	0.00174	CcSEcCtD
Olopatadine—Abdominal pain—Irinotecan—pancreatic cancer	0.000374	0.00171	CcSEcCtD
Olopatadine—Body temperature increased—Irinotecan—pancreatic cancer	0.000374	0.00171	CcSEcCtD
Olopatadine—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000374	0.00171	CcSEcCtD
Olopatadine—Nasopharyngitis—Doxorubicin—pancreatic cancer	0.000371	0.0017	CcSEcCtD
Olopatadine—Vomiting—Sunitinib—pancreatic cancer	0.000365	0.00167	CcSEcCtD
Olopatadine—Body temperature increased—Gemcitabine—pancreatic cancer	0.000364	0.00167	CcSEcCtD
Olopatadine—HRH1—digestive system—pancreatic cancer	0.000364	0.0288	CbGeAlD
Olopatadine—Rash—Sunitinib—pancreatic cancer	0.000362	0.00166	CcSEcCtD
Olopatadine—Dermatitis—Sunitinib—pancreatic cancer	0.000362	0.00165	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	0.000361	0.00165	CcSEcCtD
Olopatadine—Headache—Sunitinib—pancreatic cancer	0.00036	0.00165	CcSEcCtD
Olopatadine—Influenza—Doxorubicin—pancreatic cancer	0.000359	0.00164	CcSEcCtD
Olopatadine—Body temperature increased—Fluorouracil—pancreatic cancer	0.000358	0.00164	CcSEcCtD
Olopatadine—Weight increased—Epirubicin—pancreatic cancer	0.000353	0.00161	CcSEcCtD
Olopatadine—Cough—Docetaxel—pancreatic cancer	0.00035	0.0016	CcSEcCtD
Olopatadine—Hypersensitivity—Irinotecan—pancreatic cancer	0.000349	0.00159	CcSEcCtD
Olopatadine—Infestation NOS—Epirubicin—pancreatic cancer	0.000346	0.00158	CcSEcCtD
Olopatadine—Infestation—Epirubicin—pancreatic cancer	0.000346	0.00158	CcSEcCtD
Olopatadine—Nausea—Sunitinib—pancreatic cancer	0.000341	0.00156	CcSEcCtD
Olopatadine—Asthenia—Irinotecan—pancreatic cancer	0.00034	0.00155	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000339	0.00155	CcSEcCtD
Olopatadine—Urinary tract infection—Epirubicin—pancreatic cancer	0.000336	0.00154	CcSEcCtD
Olopatadine—Conjunctivitis—Epirubicin—pancreatic cancer	0.000336	0.00154	CcSEcCtD
Olopatadine—Hypersensitivity—Fluorouracil—pancreatic cancer	0.000334	0.00153	CcSEcCtD
Olopatadine—Dry mouth—Docetaxel—pancreatic cancer	0.000334	0.00153	CcSEcCtD
Olopatadine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	0.000334	0.00153	CcSEcCtD
Olopatadine—Asthenia—Gemcitabine—pancreatic cancer	0.000331	0.00151	CcSEcCtD
Olopatadine—Oedema—Docetaxel—pancreatic cancer	0.000327	0.0015	CcSEcCtD
Olopatadine—Weight increased—Doxorubicin—pancreatic cancer	0.000327	0.00149	CcSEcCtD
Olopatadine—Epistaxis—Epirubicin—pancreatic cancer	0.000326	0.00149	CcSEcCtD
Olopatadine—Pruritus—Gemcitabine—pancreatic cancer	0.000326	0.00149	CcSEcCtD
Olopatadine—Infection—Docetaxel—pancreatic cancer	0.000325	0.00149	CcSEcCtD
Olopatadine—Sinusitis—Epirubicin—pancreatic cancer	0.000325	0.00148	CcSEcCtD
Olopatadine—Diarrhoea—Irinotecan—pancreatic cancer	0.000324	0.00148	CcSEcCtD
Olopatadine—Nervous system disorder—Docetaxel—pancreatic cancer	0.000321	0.00147	CcSEcCtD
Olopatadine—Pruritus—Fluorouracil—pancreatic cancer	0.000321	0.00147	CcSEcCtD
Olopatadine—Infestation NOS—Doxorubicin—pancreatic cancer	0.00032	0.00146	CcSEcCtD
Olopatadine—Infestation—Doxorubicin—pancreatic cancer	0.00032	0.00146	CcSEcCtD
Olopatadine—Skin disorder—Docetaxel—pancreatic cancer	0.000318	0.00145	CcSEcCtD
Olopatadine—Diarrhoea—Gemcitabine—pancreatic cancer	0.000315	0.00144	CcSEcCtD
Olopatadine—Dizziness—Irinotecan—pancreatic cancer	0.000313	0.00143	CcSEcCtD
Olopatadine—Rhinitis—Epirubicin—pancreatic cancer	0.000311	0.00142	CcSEcCtD
Olopatadine—Conjunctivitis—Doxorubicin—pancreatic cancer	0.000311	0.00142	CcSEcCtD
Olopatadine—Urinary tract infection—Doxorubicin—pancreatic cancer	0.000311	0.00142	CcSEcCtD
Olopatadine—Diarrhoea—Fluorouracil—pancreatic cancer	0.00031	0.00142	CcSEcCtD
Olopatadine—Hypoaesthesia—Epirubicin—pancreatic cancer	0.000309	0.00141	CcSEcCtD
Olopatadine—Pharyngitis—Epirubicin—pancreatic cancer	0.000308	0.00141	CcSEcCtD
Olopatadine—Epistaxis—Doxorubicin—pancreatic cancer	0.000302	0.00138	CcSEcCtD
Olopatadine—Vomiting—Irinotecan—pancreatic cancer	0.000301	0.00138	CcSEcCtD
Olopatadine—Sinusitis—Doxorubicin—pancreatic cancer	0.0003	0.00137	CcSEcCtD
Olopatadine—Dizziness—Fluorouracil—pancreatic cancer	0.0003	0.00137	CcSEcCtD
Olopatadine—Visual impairment—Epirubicin—pancreatic cancer	0.000299	0.00137	CcSEcCtD
Olopatadine—Rash—Irinotecan—pancreatic cancer	0.000298	0.00136	CcSEcCtD
Olopatadine—Dermatitis—Irinotecan—pancreatic cancer	0.000298	0.00136	CcSEcCtD
Olopatadine—Headache—Irinotecan—pancreatic cancer	0.000296	0.00136	CcSEcCtD
Olopatadine—Vomiting—Gemcitabine—pancreatic cancer	0.000293	0.00134	CcSEcCtD
Olopatadine—Dyspnoea—Docetaxel—pancreatic cancer	0.000292	0.00133	CcSEcCtD
Olopatadine—Somnolence—Docetaxel—pancreatic cancer	0.000291	0.00133	CcSEcCtD
Olopatadine—Rash—Gemcitabine—pancreatic cancer	0.000291	0.00133	CcSEcCtD
Olopatadine—Dermatitis—Gemcitabine—pancreatic cancer	0.00029	0.00133	CcSEcCtD
Olopatadine—Eye disorder—Epirubicin—pancreatic cancer	0.00029	0.00133	CcSEcCtD
Olopatadine—Headache—Gemcitabine—pancreatic cancer	0.000289	0.00132	CcSEcCtD
Olopatadine—Vomiting—Fluorouracil—pancreatic cancer	0.000288	0.00132	CcSEcCtD
Olopatadine—Rhinitis—Doxorubicin—pancreatic cancer	0.000288	0.00132	CcSEcCtD
Olopatadine—Hypoaesthesia—Doxorubicin—pancreatic cancer	0.000286	0.00131	CcSEcCtD
Olopatadine—Rash—Fluorouracil—pancreatic cancer	0.000286	0.00131	CcSEcCtD
Olopatadine—Dermatitis—Fluorouracil—pancreatic cancer	0.000286	0.00131	CcSEcCtD
Olopatadine—Pharyngitis—Doxorubicin—pancreatic cancer	0.000285	0.0013	CcSEcCtD
Olopatadine—Headache—Fluorouracil—pancreatic cancer	0.000284	0.0013	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	0.000282	0.00129	CcSEcCtD
Olopatadine—Fatigue—Docetaxel—pancreatic cancer	0.000282	0.00129	CcSEcCtD
Olopatadine—CYP3A4—digestive system—pancreatic cancer	0.000282	0.0222	CbGeAlD
Olopatadine—Nausea—Irinotecan—pancreatic cancer	0.000281	0.00129	CcSEcCtD
Olopatadine—Immune system disorder—Epirubicin—pancreatic cancer	0.000281	0.00128	CcSEcCtD
Olopatadine—Mediastinal disorder—Epirubicin—pancreatic cancer	0.00028	0.00128	CcSEcCtD
Olopatadine—Pain—Docetaxel—pancreatic cancer	0.00028	0.00128	CcSEcCtD
Olopatadine—Visual impairment—Doxorubicin—pancreatic cancer	0.000277	0.00127	CcSEcCtD
Olopatadine—Nausea—Gemcitabine—pancreatic cancer	0.000274	0.00125	CcSEcCtD
Olopatadine—Erythema—Epirubicin—pancreatic cancer	0.00027	0.00124	CcSEcCtD
Olopatadine—Feeling abnormal—Docetaxel—pancreatic cancer	0.00027	0.00123	CcSEcCtD
Olopatadine—Nausea—Fluorouracil—pancreatic cancer	0.000269	0.00123	CcSEcCtD
Olopatadine—Eye disorder—Doxorubicin—pancreatic cancer	0.000269	0.00123	CcSEcCtD
Olopatadine—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.000268	0.00122	CcSEcCtD
Olopatadine—Dysgeusia—Epirubicin—pancreatic cancer	0.000265	0.00121	CcSEcCtD
Olopatadine—Back pain—Epirubicin—pancreatic cancer	0.000262	0.0012	CcSEcCtD
Olopatadine—Muscle spasms—Epirubicin—pancreatic cancer	0.00026	0.00119	CcSEcCtD
Olopatadine—Immune system disorder—Doxorubicin—pancreatic cancer	0.00026	0.00119	CcSEcCtD
Olopatadine—Mediastinal disorder—Doxorubicin—pancreatic cancer	0.000259	0.00118	CcSEcCtD
Olopatadine—Abdominal pain—Docetaxel—pancreatic cancer	0.000259	0.00118	CcSEcCtD
Olopatadine—Body temperature increased—Docetaxel—pancreatic cancer	0.000259	0.00118	CcSEcCtD
Olopatadine—Vision blurred—Epirubicin—pancreatic cancer	0.000255	0.00116	CcSEcCtD
Olopatadine—Ill-defined disorder—Epirubicin—pancreatic cancer	0.000251	0.00115	CcSEcCtD
Olopatadine—Erythema—Doxorubicin—pancreatic cancer	0.00025	0.00114	CcSEcCtD
Olopatadine—Dysgeusia—Doxorubicin—pancreatic cancer	0.000245	0.00112	CcSEcCtD
Olopatadine—Malaise—Epirubicin—pancreatic cancer	0.000244	0.00111	CcSEcCtD
Olopatadine—Back pain—Doxorubicin—pancreatic cancer	0.000242	0.00111	CcSEcCtD
Olopatadine—Hypersensitivity—Docetaxel—pancreatic cancer	0.000241	0.0011	CcSEcCtD
Olopatadine—Muscle spasms—Doxorubicin—pancreatic cancer	0.000241	0.0011	CcSEcCtD
Olopatadine—Cough—Epirubicin—pancreatic cancer	0.000236	0.00108	CcSEcCtD
Olopatadine—Vision blurred—Doxorubicin—pancreatic cancer	0.000236	0.00108	CcSEcCtD
Olopatadine—Asthenia—Docetaxel—pancreatic cancer	0.000235	0.00107	CcSEcCtD
Olopatadine—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000232	0.00106	CcSEcCtD
Olopatadine—Pruritus—Docetaxel—pancreatic cancer	0.000231	0.00106	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000229	0.00105	CcSEcCtD
Olopatadine—Discomfort—Epirubicin—pancreatic cancer	0.000227	0.00104	CcSEcCtD
Olopatadine—Malaise—Doxorubicin—pancreatic cancer	0.000226	0.00103	CcSEcCtD
Olopatadine—Dry mouth—Epirubicin—pancreatic cancer	0.000225	0.00103	CcSEcCtD
Olopatadine—Diarrhoea—Docetaxel—pancreatic cancer	0.000224	0.00102	CcSEcCtD
Olopatadine—Oedema—Epirubicin—pancreatic cancer	0.000221	0.00101	CcSEcCtD
Olopatadine—Infection—Epirubicin—pancreatic cancer	0.000219	0.001	CcSEcCtD
Olopatadine—Cough—Doxorubicin—pancreatic cancer	0.000218	0.000998	CcSEcCtD
Olopatadine—Nervous system disorder—Epirubicin—pancreatic cancer	0.000216	0.000989	CcSEcCtD
Olopatadine—Dizziness—Docetaxel—pancreatic cancer	0.000216	0.000989	CcSEcCtD
Olopatadine—Skin disorder—Epirubicin—pancreatic cancer	0.000214	0.00098	CcSEcCtD
Olopatadine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000212	0.000967	CcSEcCtD
Olopatadine—Discomfort—Doxorubicin—pancreatic cancer	0.00021	0.000962	CcSEcCtD
Olopatadine—Dry mouth—Doxorubicin—pancreatic cancer	0.000208	0.000952	CcSEcCtD
Olopatadine—Vomiting—Docetaxel—pancreatic cancer	0.000208	0.000951	CcSEcCtD
Olopatadine—Rash—Docetaxel—pancreatic cancer	0.000206	0.000943	CcSEcCtD
Olopatadine—Dermatitis—Docetaxel—pancreatic cancer	0.000206	0.000942	CcSEcCtD
Olopatadine—Headache—Docetaxel—pancreatic cancer	0.000205	0.000937	CcSEcCtD
Olopatadine—Oedema—Doxorubicin—pancreatic cancer	0.000204	0.000933	CcSEcCtD
Olopatadine—Infection—Doxorubicin—pancreatic cancer	0.000203	0.000927	CcSEcCtD
Olopatadine—Nervous system disorder—Doxorubicin—pancreatic cancer	0.0002	0.000915	CcSEcCtD
Olopatadine—Skin disorder—Doxorubicin—pancreatic cancer	0.000198	0.000907	CcSEcCtD
Olopatadine—Dyspnoea—Epirubicin—pancreatic cancer	0.000197	0.000899	CcSEcCtD
Olopatadine—Somnolence—Epirubicin—pancreatic cancer	0.000196	0.000897	CcSEcCtD
Olopatadine—Nausea—Docetaxel—pancreatic cancer	0.000194	0.000888	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	0.000191	0.000871	CcSEcCtD
Olopatadine—Fatigue—Epirubicin—pancreatic cancer	0.00019	0.00087	CcSEcCtD
Olopatadine—Pain—Epirubicin—pancreatic cancer	0.000189	0.000863	CcSEcCtD
Olopatadine—Dyspnoea—Doxorubicin—pancreatic cancer	0.000182	0.000832	CcSEcCtD
Olopatadine—Feeling abnormal—Epirubicin—pancreatic cancer	0.000182	0.000831	CcSEcCtD
Olopatadine—Somnolence—Doxorubicin—pancreatic cancer	0.000182	0.00083	CcSEcCtD
Olopatadine—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.00018	0.000825	CcSEcCtD
Olopatadine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	0.000176	0.000806	CcSEcCtD
Olopatadine—Fatigue—Doxorubicin—pancreatic cancer	0.000176	0.000805	CcSEcCtD
Olopatadine—Pain—Doxorubicin—pancreatic cancer	0.000175	0.000798	CcSEcCtD
Olopatadine—Body temperature increased—Epirubicin—pancreatic cancer	0.000174	0.000798	CcSEcCtD
Olopatadine—Abdominal pain—Epirubicin—pancreatic cancer	0.000174	0.000798	CcSEcCtD
Olopatadine—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000168	0.000769	CcSEcCtD
Olopatadine—Gastrointestinal pain—Doxorubicin—pancreatic cancer	0.000167	0.000763	CcSEcCtD
Olopatadine—Hypersensitivity—Epirubicin—pancreatic cancer	0.000163	0.000743	CcSEcCtD
Olopatadine—Abdominal pain—Doxorubicin—pancreatic cancer	0.000161	0.000738	CcSEcCtD
Olopatadine—Body temperature increased—Doxorubicin—pancreatic cancer	0.000161	0.000738	CcSEcCtD
Olopatadine—Asthenia—Epirubicin—pancreatic cancer	0.000158	0.000724	CcSEcCtD
Olopatadine—Pruritus—Epirubicin—pancreatic cancer	0.000156	0.000714	CcSEcCtD
Olopatadine—Diarrhoea—Epirubicin—pancreatic cancer	0.000151	0.00069	CcSEcCtD
Olopatadine—Hypersensitivity—Doxorubicin—pancreatic cancer	0.00015	0.000688	CcSEcCtD
Olopatadine—Asthenia—Doxorubicin—pancreatic cancer	0.000146	0.00067	CcSEcCtD
Olopatadine—Dizziness—Epirubicin—pancreatic cancer	0.000146	0.000667	CcSEcCtD
Olopatadine—Pruritus—Doxorubicin—pancreatic cancer	0.000144	0.00066	CcSEcCtD
Olopatadine—Vomiting—Epirubicin—pancreatic cancer	0.00014	0.000641	CcSEcCtD
Olopatadine—Diarrhoea—Doxorubicin—pancreatic cancer	0.00014	0.000639	CcSEcCtD
Olopatadine—Rash—Epirubicin—pancreatic cancer	0.000139	0.000636	CcSEcCtD
Olopatadine—Dermatitis—Epirubicin—pancreatic cancer	0.000139	0.000636	CcSEcCtD
Olopatadine—Headache—Epirubicin—pancreatic cancer	0.000138	0.000632	CcSEcCtD
Olopatadine—Dizziness—Doxorubicin—pancreatic cancer	0.000135	0.000617	CcSEcCtD
Olopatadine—Nausea—Epirubicin—pancreatic cancer	0.000131	0.000599	CcSEcCtD
Olopatadine—Vomiting—Doxorubicin—pancreatic cancer	0.00013	0.000594	CcSEcCtD
Olopatadine—Rash—Doxorubicin—pancreatic cancer	0.000129	0.000589	CcSEcCtD
Olopatadine—Dermatitis—Doxorubicin—pancreatic cancer	0.000129	0.000588	CcSEcCtD
Olopatadine—Headache—Doxorubicin—pancreatic cancer	0.000128	0.000585	CcSEcCtD
Olopatadine—S100B—Signaling Pathways—PTCH1—pancreatic cancer	0.000127	0.000685	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PIK3CB—pancreatic cancer	0.000125	0.000675	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—SHH—pancreatic cancer	0.000124	0.000666	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PRLHR—pancreatic cancer	0.000123	0.000664	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—IAPP—pancreatic cancer	0.000122	0.000658	CbGpPWpGaD
Olopatadine—Nausea—Doxorubicin—pancreatic cancer	0.000121	0.000554	CcSEcCtD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—AGTR1—pancreatic cancer	0.00012	0.000645	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—CTNNB1—pancreatic cancer	0.000117	0.000633	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—PTCH1—pancreatic cancer	0.000117	0.000631	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—PTHLH—pancreatic cancer	0.000117	0.000631	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SST—pancreatic cancer	0.000116	0.000627	CbGpPWpGaD
Olopatadine—HRH1—IL-4 Signaling Pathway—AKT1—pancreatic cancer	0.000116	0.000624	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—SSTR3—pancreatic cancer	0.000115	0.000621	CbGpPWpGaD
Olopatadine—S100A12—Immune System—BCL2L1—pancreatic cancer	0.000115	0.000618	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—PTEN—pancreatic cancer	0.000114	0.000617	CbGpPWpGaD
Olopatadine—S100A12—Immune System—TSC2—pancreatic cancer	0.000114	0.000614	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—JAG1—pancreatic cancer	0.000114	0.000613	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOTCH3—pancreatic cancer	0.000113	0.000611	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GDI1—pancreatic cancer	0.000113	0.000608	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GDI2—pancreatic cancer	0.000113	0.000608	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—CTNNB1—pancreatic cancer	0.000111	0.000598	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—SSTR1—pancreatic cancer	0.00011	0.000596	CbGpPWpGaD
Olopatadine—S100B—Immune System—BCL2L1—pancreatic cancer	0.000108	0.000584	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PPY—pancreatic cancer	0.000108	0.000584	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PTEN—pancreatic cancer	0.000108	0.000583	CbGpPWpGaD
Olopatadine—S100B—Immune System—TSC2—pancreatic cancer	0.000108	0.000581	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CNR1—pancreatic cancer	0.000107	0.000579	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—SST—pancreatic cancer	0.000107	0.000577	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—SSTR2—pancreatic cancer	0.000106	0.000573	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—SRC—pancreatic cancer	0.000106	0.000572	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—SSTR3—pancreatic cancer	0.000105	0.000564	CbGpPWpGaD
Olopatadine—S100A12—Immune System—NFKBIA—pancreatic cancer	0.000104	0.00056	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—GCG—pancreatic cancer	0.000104	0.000559	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCKBR—pancreatic cancer	0.000103	0.000554	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—NRAS—pancreatic cancer	0.000102	0.00055	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—SSTR1—pancreatic cancer	0.0001	0.000541	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—SRC—pancreatic cancer	0.0001	0.000541	CbGpPWpGaD
Olopatadine—S100A12—Immune System—EGF—pancreatic cancer	9.95e-05	0.000536	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AGTR1—pancreatic cancer	9.89e-05	0.000533	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CNR1—pancreatic cancer	9.89e-05	0.000533	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PPY—pancreatic cancer	9.84e-05	0.00053	CbGpPWpGaD
Olopatadine—S100B—Immune System—NFKBIA—pancreatic cancer	9.83e-05	0.00053	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—STK11—pancreatic cancer	9.75e-05	0.000525	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—SSTR2—pancreatic cancer	9.66e-05	0.000521	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—NRAS—pancreatic cancer	9.65e-05	0.00052	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—GCG—pancreatic cancer	9.55e-05	0.000515	CbGpPWpGaD
Olopatadine—S100B—Immune System—EGF—pancreatic cancer	9.41e-05	0.000507	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCKBR—pancreatic cancer	9.33e-05	0.000503	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—EGFR—pancreatic cancer	9.3e-05	0.000501	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CDH1—pancreatic cancer	9.26e-05	0.000499	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—AGTR1—pancreatic cancer	9.11e-05	0.000491	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PIK3CD—pancreatic cancer	8.85e-05	0.000477	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GAST—pancreatic cancer	8.83e-05	0.000476	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—EGFR—pancreatic cancer	8.79e-05	0.000474	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—KRAS—pancreatic cancer	8.78e-05	0.000474	CbGpPWpGaD
Olopatadine—S100B—Immune System—CDH1—pancreatic cancer	8.76e-05	0.000472	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SMAD4—pancreatic cancer	8.54e-05	0.00046	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—SCT—pancreatic cancer	8.37e-05	0.000451	CbGpPWpGaD
Olopatadine—S100B—Immune System—PIK3CD—pancreatic cancer	8.37e-05	0.000451	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HES1—pancreatic cancer	8.33e-05	0.000449	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—KRAS—pancreatic cancer	8.31e-05	0.000448	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—PIK3CA—pancreatic cancer	8.07e-05	0.000435	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GAST—pancreatic cancer	8.02e-05	0.000432	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCK—pancreatic cancer	7.99e-05	0.000431	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CNR2—pancreatic cancer	7.78e-05	0.00042	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GLP1R—pancreatic cancer	7.78e-05	0.00042	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PIK3CB—pancreatic cancer	7.71e-05	0.000416	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CCKAR—pancreatic cancer	7.66e-05	0.000413	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—PIK3CA—pancreatic cancer	7.63e-05	0.000411	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—SCT—pancreatic cancer	7.6e-05	0.00041	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—HRAS—pancreatic cancer	7.47e-05	0.000403	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TERT—pancreatic cancer	7.3e-05	0.000394	CbGpPWpGaD
Olopatadine—S100B—Immune System—PIK3CB—pancreatic cancer	7.29e-05	0.000393	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PRLHR—pancreatic cancer	7.27e-05	0.000392	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCK—pancreatic cancer	7.25e-05	0.000391	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CNR2—pancreatic cancer	7.07e-05	0.000381	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GLP1R—pancreatic cancer	7.07e-05	0.000381	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—HRAS—pancreatic cancer	7.06e-05	0.000381	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HIF1A—pancreatic cancer	6.98e-05	0.000376	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TSC2—pancreatic cancer	6.97e-05	0.000376	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CCKAR—pancreatic cancer	6.95e-05	0.000375	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—IAPP—pancreatic cancer	6.9e-05	0.000372	CbGpPWpGaD
Olopatadine—S100A12—Immune System—CTNNB1—pancreatic cancer	6.84e-05	0.000369	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ZNRF3—pancreatic cancer	6.84e-05	0.000369	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—ACVR1B—pancreatic cancer	6.84e-05	0.000369	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—APOE—pancreatic cancer	6.82e-05	0.000368	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—KDR—pancreatic cancer	6.68e-05	0.00036	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PTEN—pancreatic cancer	6.66e-05	0.000359	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PTHLH—pancreatic cancer	6.62e-05	0.000357	CbGpPWpGaD
Olopatadine—S100A12—Innate Immune System—AKT1—pancreatic cancer	6.59e-05	0.000355	CbGpPWpGaD
Olopatadine—S100B—Immune System—CTNNB1—pancreatic cancer	6.46e-05	0.000348	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NFKBIA—pancreatic cancer	6.35e-05	0.000342	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—SHH—pancreatic cancer	6.34e-05	0.000342	CbGpPWpGaD
Olopatadine—S100B—Immune System—PTEN—pancreatic cancer	6.3e-05	0.00034	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NOTCH1—pancreatic cancer	6.29e-05	0.000339	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—IAPP—pancreatic cancer	6.26e-05	0.000338	CbGpPWpGaD
Olopatadine—S100B—Innate Immune System—AKT1—pancreatic cancer	6.23e-05	0.000336	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SSTR3—pancreatic cancer	6.18e-05	0.000333	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DTX1—pancreatic cancer	6.18e-05	0.000333	CbGpPWpGaD
Olopatadine—S100A12—Immune System—SRC—pancreatic cancer	6.18e-05	0.000333	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CG—pancreatic cancer	6.15e-05	0.000332	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—EGF—pancreatic cancer	6.08e-05	0.000328	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—SST—pancreatic cancer	6.05e-05	0.000326	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PTHLH—pancreatic cancer	6.01e-05	0.000324	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PTCH1—pancreatic cancer	6.01e-05	0.000324	CbGpPWpGaD
Olopatadine—S100A12—Immune System—STAT3—pancreatic cancer	5.96e-05	0.000321	CbGpPWpGaD
Olopatadine—S100A12—Immune System—NRAS—pancreatic cancer	5.94e-05	0.00032	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—pancreatic cancer	5.94e-05	0.00032	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SSTR1—pancreatic cancer	5.93e-05	0.00032	CbGpPWpGaD
Olopatadine—S100B—Immune System—SRC—pancreatic cancer	5.84e-05	0.000315	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PPY—pancreatic cancer	5.81e-05	0.000313	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SSTR2—pancreatic cancer	5.71e-05	0.000308	CbGpPWpGaD
Olopatadine—S100B—Immune System—STAT3—pancreatic cancer	5.64e-05	0.000304	CbGpPWpGaD
Olopatadine—S100B—Immune System—NRAS—pancreatic cancer	5.62e-05	0.000303	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CNR1—pancreatic cancer	5.59e-05	0.000301	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCKBR—pancreatic cancer	5.51e-05	0.000297	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—SST—pancreatic cancer	5.5e-05	0.000296	CbGpPWpGaD
Olopatadine—HRH1—Class A/1 (Rhodopsin-like receptors)—CXCL8—pancreatic cancer	5.48e-05	0.000295	CbGpPWpGaD
Olopatadine—S100A12—Immune System—EGFR—pancreatic cancer	5.42e-05	0.000292	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pancreatic cancer	5.41e-05	0.000292	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CD—pancreatic cancer	5.41e-05	0.000292	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—GCG—pancreatic cancer	5.4e-05	0.000291	CbGpPWpGaD
Olopatadine—HRH1—G alpha (q) signalling events—PIK3CA—pancreatic cancer	5.25e-05	0.000283	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—DTX4—pancreatic cancer	5.18e-05	0.000279	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GLI1—pancreatic cancer	5.18e-05	0.000279	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AGTR1—pancreatic cancer	5.15e-05	0.000277	CbGpPWpGaD
Olopatadine—S100B—Immune System—EGFR—pancreatic cancer	5.12e-05	0.000276	CbGpPWpGaD
Olopatadine—S100A12—Immune System—KRAS—pancreatic cancer	5.12e-05	0.000276	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—pancreatic cancer	5.11e-05	0.000275	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CNR1—pancreatic cancer	5.07e-05	0.000274	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NRP1—pancreatic cancer	5.04e-05	0.000272	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PPP2R5B—pancreatic cancer	5.04e-05	0.000272	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—GCG—pancreatic cancer	4.9e-05	0.000264	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HEY2—pancreatic cancer	4.85e-05	0.000262	CbGpPWpGaD
Olopatadine—S100B—Immune System—KRAS—pancreatic cancer	4.84e-05	0.000261	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GAST—pancreatic cancer	4.74e-05	0.000255	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CB—pancreatic cancer	4.71e-05	0.000254	CbGpPWpGaD
Olopatadine—S100A12—Immune System—PIK3CA—pancreatic cancer	4.7e-05	0.000253	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—pancreatic cancer	4.7e-05	0.000253	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AGTR1—pancreatic cancer	4.67e-05	0.000252	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CXCL8—pancreatic cancer	4.53e-05	0.000244	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SCT—pancreatic cancer	4.49e-05	0.000242	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HEY1—pancreatic cancer	4.49e-05	0.000242	CbGpPWpGaD
Olopatadine—S100B—Immune System—PIK3CA—pancreatic cancer	4.45e-05	0.00024	CbGpPWpGaD
Olopatadine—S100A12—Immune System—HRAS—pancreatic cancer	4.35e-05	0.000234	CbGpPWpGaD
Olopatadine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—pancreatic cancer	4.34e-05	0.000234	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CASP3—pancreatic cancer	4.34e-05	0.000234	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCK—pancreatic cancer	4.29e-05	0.000231	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CCND1—pancreatic cancer	4.22e-05	0.000228	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—CTNNB1—pancreatic cancer	4.18e-05	0.000225	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CNR2—pancreatic cancer	4.18e-05	0.000225	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GLP1R—pancreatic cancer	4.18e-05	0.000225	CbGpPWpGaD
Olopatadine—HRH1—GPCR ligand binding—CXCL8—pancreatic cancer	4.17e-05	0.000225	CbGpPWpGaD
Olopatadine—S100B—Immune System—HRAS—pancreatic cancer	4.11e-05	0.000222	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCKAR—pancreatic cancer	4.11e-05	0.000221	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MMP9—pancreatic cancer	4.1e-05	0.000221	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PTEN—pancreatic cancer	4.07e-05	0.00022	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JAG2—pancreatic cancer	3.98e-05	0.000215	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MEN1—pancreatic cancer	3.93e-05	0.000212	CbGpPWpGaD
Olopatadine—S100A12—Immune System—AKT1—pancreatic cancer	3.84e-05	0.000207	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—SRC—pancreatic cancer	3.78e-05	0.000204	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SHH—pancreatic cancer	3.75e-05	0.000202	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOTCH4—pancreatic cancer	3.72e-05	0.000201	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—IAPP—pancreatic cancer	3.7e-05	0.000199	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—VEGFA—pancreatic cancer	3.68e-05	0.000198	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—STAT3—pancreatic cancer	3.64e-05	0.000196	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—NRAS—pancreatic cancer	3.63e-05	0.000196	CbGpPWpGaD
Olopatadine—S100B—Immune System—AKT1—pancreatic cancer	3.63e-05	0.000196	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTHLH—pancreatic cancer	3.55e-05	0.000191	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTCH1—pancreatic cancer	3.55e-05	0.000191	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—MYC—pancreatic cancer	3.39e-05	0.000183	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TGFB1—pancreatic cancer	3.38e-05	0.000182	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—EGFR—pancreatic cancer	3.31e-05	0.000179	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SST—pancreatic cancer	3.25e-05	0.000175	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CG—pancreatic cancer	3.2e-05	0.000173	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—JAG1—pancreatic cancer	3.18e-05	0.000171	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PRSS1—pancreatic cancer	3.18e-05	0.000171	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOTCH3—pancreatic cancer	3.16e-05	0.000171	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—KRAS—pancreatic cancer	3.13e-05	0.000169	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CNR1—pancreatic cancer	3e-05	0.000162	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CG—pancreatic cancer	2.91e-05	0.000157	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—GCG—pancreatic cancer	2.89e-05	0.000156	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—PIK3CA—pancreatic cancer	2.87e-05	0.000155	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CD—pancreatic cancer	2.82e-05	0.000152	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—TP53—pancreatic cancer	2.78e-05	0.00015	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AGTR1—pancreatic cancer	2.76e-05	0.000149	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—ARG2—pancreatic cancer	2.75e-05	0.000148	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—STK11—pancreatic cancer	2.72e-05	0.000147	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—HRAS—pancreatic cancer	2.66e-05	0.000143	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CD—pancreatic cancer	2.56e-05	0.000138	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CB—pancreatic cancer	2.45e-05	0.000132	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—TYMP—pancreatic cancer	2.41e-05	0.00013	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SMAD4—pancreatic cancer	2.38e-05	0.000128	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—CXCL8—pancreatic cancer	2.36e-05	0.000127	CbGpPWpGaD
Olopatadine—S100B—Signaling Pathways—AKT1—pancreatic cancer	2.35e-05	0.000127	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HES1—pancreatic cancer	2.33e-05	0.000125	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CB—pancreatic cancer	2.23e-05	0.00012	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—CXCL8—pancreatic cancer	2.14e-05	0.000115	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TERT—pancreatic cancer	2.04e-05	0.00011	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HIF1A—pancreatic cancer	1.95e-05	0.000105	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TSC2—pancreatic cancer	1.95e-05	0.000105	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GLP1R—pancreatic cancer	1.94e-05	0.000105	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—DPYD—pancreatic cancer	1.91e-05	0.000103	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—APOE—pancreatic cancer	1.9e-05	0.000103	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KDR—pancreatic cancer	1.87e-05	0.000101	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	1.81e-05	9.76e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NFKBIA—pancreatic cancer	1.77e-05	9.56e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NOTCH1—pancreatic cancer	1.76e-05	9.47e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CG—pancreatic cancer	1.72e-05	9.26e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—NRAS—pancreatic cancer	1.72e-05	9.26e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EGF—pancreatic cancer	1.7e-05	9.16e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—EGFR—pancreatic cancer	1.57e-05	8.44e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CD—pancreatic cancer	1.51e-05	8.14e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—PIK3CA—pancreatic cancer	1.5e-05	8.07e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—KRAS—pancreatic cancer	1.48e-05	7.97e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—CD44—pancreatic cancer	1.4e-05	7.56e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—PIK3CA—pancreatic cancer	1.36e-05	7.32e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—GCG—pancreatic cancer	1.34e-05	7.25e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CB—pancreatic cancer	1.32e-05	7.1e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CXCL8—pancreatic cancer	1.27e-05	6.82e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—STK11—pancreatic cancer	1.26e-05	6.82e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—HRAS—pancreatic cancer	1.26e-05	6.78e-05	CbGpPWpGaD
Olopatadine—HRH1—GPCR downstream signaling—AKT1—pancreatic cancer	1.22e-05	6.59e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CASP3—pancreatic cancer	1.21e-05	6.53e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CCND1—pancreatic cancer	1.18e-05	6.35e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—CTNNB1—pancreatic cancer	1.17e-05	6.29e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MMP9—pancreatic cancer	1.14e-05	6.17e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PTEN—pancreatic cancer	1.14e-05	6.13e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling by GPCR—AKT1—pancreatic cancer	1.11e-05	5.98e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—TYMS—pancreatic cancer	1.09e-05	5.86e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—SRC—pancreatic cancer	1.06e-05	5.69e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—VEGFA—pancreatic cancer	1.03e-05	5.54e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—STAT3—pancreatic cancer	1.02e-05	5.49e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—NRAS—pancreatic cancer	1.02e-05	5.47e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—MYC—pancreatic cancer	9.46e-06	5.1e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TGFB1—pancreatic cancer	9.43e-06	5.08e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—EGFR—pancreatic cancer	9.25e-06	4.99e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—APOE—pancreatic cancer	8.84e-06	4.77e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—KRAS—pancreatic cancer	8.74e-06	4.71e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—PIK3CA—pancreatic cancer	8.03e-06	4.33e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	7.98e-06	4.3e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—TP53—pancreatic cancer	7.76e-06	4.19e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PPARG—pancreatic cancer	7.7e-06	4.15e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—HRAS—pancreatic cancer	7.43e-06	4e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	7.02e-06	3.78e-05	CbGpPWpGaD
Olopatadine—HRH1—Signaling Pathways—AKT1—pancreatic cancer	6.56e-06	3.53e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	6.12e-06	3.3e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTGS2—pancreatic cancer	6.06e-06	3.27e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PTEN—pancreatic cancer	5.29e-06	2.85e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	3.73e-06	2.01e-05	CbGpPWpGaD
Olopatadine—CYP3A4—Metabolism—AKT1—pancreatic cancer	3.05e-06	1.64e-05	CbGpPWpGaD
